title: Efficacy of tylosin tablets for the treatment of pyoderma due to Staphylococcus intermedius infection in dogs.
abstract: Tylosin tablets (20 mg/kg, q12h) were administered orally to 21 dogs with superficial or deep staphylococcal pyodermas. Response to therapy was excellent in 90.5% of the dogs, and in vitro susceptibility testing correlated perfectly with therapeutic response. Duration of therapy varied from 17 to 91 days, with an average of 33 days. Relapses occurred in 28.6% of the dogs within a three-month period. No side effects were reported. Under the conditions of the study, tylosin was an effective and safe antibiotic for the treatment of staphylococcal pyoderma in dogs.
authors.affiliation: Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853.
authors.forename: D W
authors.initials: DW
authors.lastname: Scott
authors.forename: W H
authors.initials: WH
authors.lastname: Miller
authors.forename: S M
authors.initials: SM
authors.lastname: Cayatte
authors.forename: M S
authors.initials: MS
authors.lastname: Bagladi
mesh_terms: D000284:Administration, Oral; D000818:Animals; D004283:Dog Diseases / Q000188:drug therapy* / Q000382:microbiology; D004285:Dogs; D005260:Female; D008297:Male; D011711:Pyoderma / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary*; D012008:Recurrence; D013207:Staphylococcal Skin Infections / Q000188:drug therapy / Q000662:veterinary*; D013607:Tablets; D015645:Tylosin / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D013607:Tablets; D015645:Tylosin